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Viral noncoding RNAs have been shown to play an
important role in virus-host interplay to facilitate virus
replication. We report that members of the genus
Flavivirus, a large group of medically important en-
cephalitic RNA viruses, produce a unique and highly
structured noncoding RNA of 0.3–0.5 kb derived
from the 30 untranslated region of the viral genome.
Using West Nile virus as a model, we show that this
subgenomic RNA is a product of incomplete degra-
dation of viral genomic RNA by cellular ribonucleases.
Highly conserved RNA structures located at the be-
ginning of the 30 untranslated region render this RNA
resistant to nucleases, and the resulting subgenomic
RNA product is essential for virus-induced cytopa-
thicity and pathogenicity. Thus, flaviviruses evolved
a unique strategy to generate a noncoding RNA prod-
uct that allows them to kill the host more efficiently.
INTRODUCTION
Arthropod-borne Flaviviruses such as West Nile (WNV), dengue
(DENV), Yellow fever (YFV), Tick-borne encephalitis (TBEV),
and Japanese encephalitis (JEV) cause major outbreaks of
potentially fatal diseases and affect more than 50 million people
every year. The highly pathogenic North American strain of WNV
(WNVNY99) has already claimed more than 1,000 lives with more
than 27,000 cases reported since its emergence in New York in
1999. In contrast, the closely related Australian strain of WNV,
Kunjin (WNVKUN), is highly attenuated and does not cause overt
disease in humans and animals (Hall et al., 2002). The 11 kb
positive-stranded flavivirus RNA genome consists of 50 and 30
untranslated regions (UTRs) and one open reading frame, which
encodes 10 viral proteins required for the viral life cycle (Liu et al.,
2002, 2003, 2004, 2005, 2006; Westaway et al., 2003). Flavivirus
UTRs are involved in translation and initiation of RNA replication
and likely determine genome packaging (Markoff, 2003;Cell HostWestaway et al., 2002). In addition to full-length genomic RNA
(gRNA), an abundant RNA species of about 0.5 kb derived
from the 30UTR has been detected in cells infected with mos-
quito-borne encephalitic flaviviruses Murray Valley encephalitis
(MVE) (Urosevic et al., 1997), JEV (Lin et al., 2004), and WNV
(Scherbik et al., 2006). However, themechanism of its generation
and function in the viral replication cycle remained unknown.
Processing bodies (PBs, also known as GW bodies) are
discrete cytoplasmic granules in which mRNA degradation,
mRNA surveillance, translational repression, and RNA-mediated
gene silencing take place (Eulalio et al., 2007). mRNA degrada-
tion can occur through two distinct pathways: (1) deadenylation
followed by degradation through 30-50decay mediated by the
exosome and (2) decapping and degradation by a 50-to-30 exo-
nucleolytic process (Tourriere et al., 2002; Wilusz et al., 2001).
The latter occurs primarily in PBs in which mRNAs are decapped
by Dcp1/2 and subsequently degraded by the 50-30 exoribonu-
clease XRN1 (Sheth and Parker, 2003). XRN1 is a processive
enzyme hydrolyzing RNA from the 50 to 30 end and an essential
component of cellular mRNA decay machinery (Sheth and
Parker, 2003; Stevens, 2001). Interestingly, flavivirus gRNA has
no 30poly(A) tail but a cap at the 50 end that may target it to
PBs for decapping and XRN1-mediated decay.
For the yeast homolog Xrn1p, it has been shown that certain
structures in the target RNA influence efficiency of 50-30 exoribo-
nucleolytichydrolysis (PooleandStevens, 1997). The30UTRoffla-
viviruses contains a number of highly structured regions, for some
of which functions have been assigned (Markoff, 2003; Proutski
et al., 1999), while no functions have been determined for other
highly structured regions. Here, we show that the accumulation
of a subgenomic 30UTR-derivedRNA is a specific feature ofmem-
bers of the flavivirus genus, and, usingWest Nile virus as amodel,
we demonstrate that this subgenomic flavivirus RNA (sfRNA) is
generated as a product of gRNA degradation presumably by
XRN1 exoribonuclease. We also provide evidence that the pro-
duction of sfRNA is likely to be a result of XRN1 stalling mediated
by rigid, conserved RNA structures in the 50 end of the 30UTR.
Importantly, we demonstrate that sfRNA has a role in facilitating
efficient virus replication and virus-induced cytopathicity in cell
culture and in determining viral pathogenicity in mice.& Microbe 4, 579–591, December 11, 2008 ª2008 Elsevier Inc. 579
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Generation and Function of sfRNAFigure 1. Flaviviruses Produce a Subgenomic RNA Species in Infected Cells
Cells were either infected with indicated viruses or transfected with replicon RNAs and analyzed for accumulation of virus-specific RNA species by northern blot
hybridization detecting the 30UTR.
(A) WNV subtype Kunjin (KUN), WNV strain NY99 (NY99), Murray Valley (MVE), Alfuy (ALF), Yellow Fever (YFV), dengue 2 replicon (DEN2); all RNAs isolated from
infected/transfected BHK-21 cells.
(B) Samaurez Reef virus (SREV); RNA from infected PS-EK cells.
(C) Bovine viral diarrhea virus (BVDV); RNA from infected MDBK cells.
(D) Hepatitis C virus (HCV); RNA from HCV replicon-transfected Huh7 cells.
(E) Semliki Forest virus (SFV); RNA from SFV replicon RNA-transfected BHK-21 cells. sgRNA represents SFV subgenomic RNA produced from internal 26S
promoter.
Arrowheads indicate sfRNA produced by YFV (open) and DEN2 (solid). RNA size markers (kb) are indicated.RESULTS
Accumulation of Subgenomic RNA Is a Unique Feature
of the Genus Flavivirus, Is Not Cell-Type Specific,
and Is Not a Result of RNA Self-Cleavage
To investigate whether the production of subgenomic RNA
species is common for all flaviviruses, cells were either infected
with different viruses or electroporated with their replicon
RNAs. Northern hybridizations with the corresponding 30UTR-
specific probes showed that cells infected with mosquito-borne
WNVKUN, WNVNY99, MVEV, Alfuy (ALFV), and tick-borne
Samaurez Reef virus (SREV) all produced a subgenomic RNA
of similar size (0.5 kb), while YFV-infected cells and a replicon
of DENV type 2 (DENV2) produced slightly smaller RNAs (0.3
and 0.4 kb, respectively), correlating with the corresponding
30UTR sizes (Figures 1A and 1B). In contrast, cells infected with
viruses from other Flaviviridae genera, bovine viral diarrhea virus
(BVDV; Pestiviruses) and (a replicon of) hepatitis C virus (HCV;
Hepaciviruses), did not produce a subgenomic, 30UTR-derived
RNA (Figures 1C and 1D). Production of small subgenomic
RNAwas also not detected for a replicon of the unrelated Semliki
Forest virus (SFV; Togaviridae, Alphaviruses) (Figure 1E). Taken
together, the results show that generation of the subgenomic,
30UTR-derived RNA is restricted to and conserved in the Flavivi-
rus genus of the Flaviviridae family; thus, we designated it as
subgenomic flavivirus RNA (sfRNA). Further analysis of sfRNA
production by WNVKUN showed that it is produced in abundant
amounts in all cell types tested, including those of vertebrate
(human, primate, and rodent) and invertebrate (mosquito) origin
(Figure S1A available online). In addition, sfRNA was shown to580 Cell Host & Microbe 4, 579–591, December 11, 2008 ª2008 Elsbe produced in WNVKUN-infected mouse brain but was not
packaged into virions and not a product of RNA self-cleavage
in vitro under the conditions used (Figure S1B), clearly indicating
the involvement of host or viral proteins in sfRNA generation.
Generation of sfRNA Does Not Require Viral RNA
Replication, Viral Proteins, or 50UTR
To further elucidate the mechanism of sfRNA generation, we in-
vestigated whether the production of sfRNA was dependent on
viral RNA replication, expression of viral proteins, or presence
of the 50UTR. Experiments with WNVKUN RNA or cDNA clones
producing RNAs containing various deletions in the viral genome
from a CMV promoter (Figure 2A and Supplemental Data)
showed that sfRNA could be readily detected in cells transfected
with all deletion constructs, replicating (KUNrep and pKUNrep2-
bgal) or nonreplicating (all remaining constructs) (Figures 2B, 2C,
and 2D and Supplemental Data), thus demonstrating that RNA
replication, viral proteins, or the 50UTR are not essential for
sfRNA generation. The results clearly showed that cellular
proteins/factors rather than viral proteins are responsible for
sfRNA production.
sfRNA Is a Product of Incomplete Degradation
of Genomic RNA by a Cellular Ribonuclease
Having excluded the role of viral factors in sfRNA generation
and taking into account that sfRNA represents the 30-terminal
product of genomic RNA, we hypothesized that a cellular ribonu-
clease with 50-30 RNA hydrolyzing activity may be responsible for
its generation. As XRN1 is the only known enzyme with such
activity in the cytoplasm of eukaryotic cells, it was logical toevier Inc.
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hypothesis, we analyzed the effect of XRN1 depletion by siRNA
on sfRNA generation in virus-infected cells. Depletion of XRN1 in
two different cell lines, A549 and SVGA (by about 90% and 67%,
respectively), resulted in a significant decrease in the amount of
sfRNA (by 56% and 47%, respectively) compared to cells trans-
fected with control siRNA (Figure 3A). In another XRN1 depletion
experiment in A549 cells, sfRNAwas reduced by 52%. Statistical
analysis of sfRNA production after XRN1 knockdown in these
three independent experiments showed that sfRNAwas reduced
by 51.7% ± 4.5%. Thus, the results demonstrate reproducible
downregulation of sfRNA production in XRN1-depleted cells.
Combined FISH and immunofluorescence analysis showed
that viral 30UTR-containing RNA partially colocalized with
XRN1 in PBs of WNVKUN-infected cells (Figure 3B). Later (30 hr)
in infection, 22% ± 7% of RNA-labeled foci overlapped with
XRN1-containing foci (right panels in Figure 3B). In contrast,
staining of SFV-infected cells for SFV RNA and XRN1 showed
no SFV RNA in PBs (Figure 3C). The siRNA depletion and coloc-
alization results suggest that XRN1 is likely to be involved in
sfRNA generation and that this processmay occur in PBs. To de-
termine whether sfRNA is indeed resistant to XRN1 degradation,
we performed in vitro digestion of total RNA isolated from
WNVKUN-infected cells with recombinant XRN1. This enzyme
Figure 2. sfRNA Production Is Independent of RNA
Replication, Viral Proteins, or 50UTR
(A) Schematic representation of WNVKUN (KUN) and replicon
(KUNrep) genome organization as well as CMV-promoter-
driven WNVKUN replicon plasmids containing various dele-
tions. Only KUN, repKUN, and pKUNrep2-bgal constructs
produce replicating RNA; remaining constructs produce
nonreplicating RNAs. C20, 20 amino acids from Core gene;
b-gal, b-galactosidase reporter gene; E22, 22 amino acids
from E gene; PAC, puromycin N-acetyltransferase gene.
(B) Northern blot of RNA isolated from BHK-21 cells infected
with WNVKUN or electroporated with WNVKUN replicon RNA.
(C) Northern blot of RNA from BHK-21 cells transfected with
pKUNrep2-bgal or pKUNrep2-bgalDGDD. An RNA size
marker is indicated (kb).
(D) Northern blot of RNA isolated from BHK-21 cells trans-
fected with replicon constructs containing various deletions.
A radiolabeled 30UTR probe was used for all northern blots.
repRNA, replicon RNA.
was able to completely degrade RNA substrates
from SFV and HCV (data not shown). In contrast,
sfRNA was shown to be resistant to XRN1 treat-
ment (Figure 3D), while it was readily degraded by
treatment with other RNases, namely RNaseA
and RNaseONE (Figure 3D). The results indicate
that XRN1 is unable to degrade sfRNA and further
implicate that sfRNA may be a product of XRN1
stalling.
Mapping of sfRNA and RNA Structure
Predictions
Northern hybridization mapping of RNA isolated
from WNVKUN-infected cells with radiolabeled
probes specific for different regions of the 30UTR
demonstrated that sfRNA corresponds to the last part of the
30UTR (Figures S2A and S2B). Primer extension analysis showed
that sfRNA isolated from WNVKUN and WNVNY99-infected cells
or isolated from infected mouse brain had a size of 525 nt
(Figure S2C).
Flavivirus 30UTR has a number of characteristic features (Fig-
ure 4A), including an AU-rich region at the 50 end, a number
of conserved (repeated) sequences (CS1/2/3 and RCS2/3), a
cyclization sequence, putative RNA pseudoknots (PKs), a penta-
nucleotide, and a conserved stem-loop structure at the 30 termi-
nus (30SL) (Markoff, 2003). Using RNA structure prediction on
a 30UTR sequence alignment of different flaviviruses, we
predicted a common RNA structure (designated SL-II) with re-
markable similarity in overall architecture between the different
viruses (Figure 4B). The high conservation of this complex RNA
structure and location of the sfRNA 50 end at its base suggest
that this structure may be involved in protecting downstream
30UTR RNA from degradation. Indeed, sfRNA sizes of 525 nt
for WNVKUN and WNVNY99 (Figure 1A), 521–523 nt for JEV (Lin
et al., 2004), 0.5 kb for MVEV (Urosevic et al., 1997) and ALFV
(Figure 1A), 0.4 kb for DENV2 (Figure 1A), and 0.3 kb for YFV
(Figure 1A) correspond well to the respective locations of SL-II
(SL-E in YFV) in the 30UTRs (Figure 4B). The SL-II structure is
remarkably similar to the previously predicted SL-IV structureCell Host & Microbe 4, 579–591, December 11, 2008 ª2008 Elsevier Inc. 581
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beginning of the SL-II structure. Both WNV SL-II and SL-IV are
followed by short conserved hairpins previously designated
RCS3 and CS3, respectively (Figure 4A) (Khromykh and West-
away, 1994). Sequence alignment of SL-II and SL-IV of WNVKUN,
WNVNY99, JEV, MVEV, ALFV, DENV2, and SL-E of YFV (Proutski
Figure 3. sfRNA Is Reduced in XRN1-Depleted WNVKUN-Infected Cells, Colocalizes with XRN1 in Processing Bodies, and Is Resistant
to XRN1 Degradation
(A) XRN1 depletion leads to decrease in sfRNA production in A549 and SVGA cells. (Top)Western blot detection of XRN1 and KUNNS5 proteins at 24 h.p.i. Rel.%
represents percentage of XRN1 expression in cells treated with siRNA against XRN1 (siXRN1) compared to that in cells transfected with control siRNA (siEGFP).
(Bottom) Northern blot with radiolabeled 30UTR probe to quantify sfRNA (%) in XRN1-depleted cells. A representative of two independent experiments for
A549 cells is shown.
(B) XRN1 colocalization with flavivirus 30UTR. WNVKUN-infected A549 cells were analyzed for viral RNA localization by FISH using FITC-labeled, 30UTR-specific
RNA probe and for XRN1 by immunofluorescence staining. Middle panels show labeling at 24 h.p.i.; right panels at 30 h.p.i. Arrows indicate colocalization.
(C) SFV-RNA does not colocalize with XRN1. SFV-infected A549 cells were analyzed as described above using a FITC-labeled 30UTR SFV-RNA probe.
(D) Resistance of sfRNA to digestion with 50-30 exoribonuclease XRN1. RNA isolated from WNVKUN-infected BHK-21 cells was digested with the indicated
nucleases, followed by northern blotting and hybridization with radiolabeled 30UTR probe.582 Cell Host & Microbe 4, 579–591, December 11, 2008 ª2008 Elsevier Inc.
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(Figure S3) that appear to form the backbone of the predicted
SL-II (SL-E) and SL-IV RNA structures (Figure 4B).
RNA Structure/Sequence Requirements for sfRNA
Generation
To experimentally determine the RNA structure responsible for
protection of 30UTR from degradation, we generated an exten-
sive series of recombinant viruses with various deletions and
mutations in the 30UTR (Figure 4C) and determined their effect
on sfRNA generation in infected cells (see Supplemental Data
for more detailed description). Northern blot analysis showed
that deletions/mutations in SL-II, as expected, resulted in the
loss of full-length sfRNA (termed sfRNA1) (Figure 4D), supporting
its essential role in sfRNA production. Additional deletions down-
stream of SL-II led to the production of two smaller, less abun-
dant sfRNA species termed sfRNA2 and sfRNA3 (Figure 4D),
suggesting that two additional rigid secondary/tertiary RNA
structures downstream of SL-II, likely to be SL-IV and DB1
(Figure 4A), can protect WNVKUN RNA from complete degrada-
tion. Importantly, plaque size and virus growth in mammalian
and mosquito cells correlated with the generation and amount
of full-length sfRNA1 (Figures 4E and 4F), showing that produc-
tion of abundant amounts of full-length sfRNA1 is essential for
efficient viral replication.
To confirm the uniqueness of flavivirus 30UTRRNA structure(s)
in the ability to protect from degradation, another highly struc-
tured RNA, internal ribosomal entry site (IRES) from encephalo-
myocarditis virus (EMCV) followed by neomycin transferase
sequence (neo), was inserted upstream of SL-II in the 30UTR of
the WNV replicon WN-NeoRep (Shi et al., 2002) (Figure S4A),
and cells stably expressing this replicon were generated by
selection with G418. When total RNA isolated from these cells
was subjected to northern blot analysis with 30UTR-specific
probe, only sfRNA1, but no other larger RNA-encompassing
IRES-neo insertion, was detected (Figure S4B), demonstrating
that the 50 end of sfRNA1, but not the IRES structure, prevents
degradation. This provides additional evidence for the unique-
ness of flavivirus 30UTR structure(s) in their ability to protect
downstream RNA sequences from degradation.
sfRNA Production Is Required for Viral Cytopathicity
in Cell Culture
To further characterize sfRNA function, a mutant virus not capa-
ble of producing sfRNA1 and sfRNA2 with minimal changes in
RNA structure, FL-IRADCS3 was constructed. The mutations
consisted of a 3 nt substitution in the IRA within SL-II and
a 10 nt deletion of the CS3 sequence (DCS3) downstream of
SL-IV (Figure 4C). As shown above, IRA mutation abolished
sfRNA1 production (Figure 4D, lane 15), while DCS3 mutation
abolished sfRNA2 production (Figure 4D, lane 9). The mutant vi-
rus with combined IRADCS3 mutations showed a severe defect
in the production of sfRNA1 (Figure 5A, lanes 5 and 6), no visible
plaque formation in Vero cells (Figure 5B), and decreased repli-
cation efficiency in mammalian (Vero) andmosquito (C6/36) cells
(Figures 5C and 5D). However, maximum differences in virus
titers were only about 5- to 10-fold. The mutant FL-IRA contain-
ing only 3 nt substitution in SL-II abolishing sfRNA1 production
was also compromised in the ability to form clearly visibleCell Hostplaques (Figure 5B), but not so much in replication efficiency
(Figures 5C and 5D). The mutations/deletions did not have a
major effect on RNA translation, replication, or packaging
efficiencies when introduced into replicon RNAs (Figure S5). To
analyze the apparent discrepancy between dramatic differences
in plaque morphology and only moderate differences in virus
growth kinetics, mutant viruses were investigated for induction
of cytopathicity. The number of viable cells was significantly
higher in wells infected with FL-IRA and FL-IRADCS3 compared
to FLSDX and FLDCS3 (Figure 6A). Quantification analysis using
released crystal violet stain showed clear differences in cyto-
pathic effect (CPE) with about 70% of cells dead at 6 days post-
infection (d.p.i.) with FLSDX and only 10% or less of cells dead
after infection with either FL-IRA or FL-IRADCS3 mutants
(Figure 6B). This difference in viral cytopathicity was confirmed
by measuring the release of lactate dehydrogenase (LDH) by
dying cells into the cell culture supernatant (Figure 6C).
To investigate whether sfRNA production alone induces cell
death, the plasmid pCMVbgal30 producing sfRNA without other
viral components was transfected, and cell death was assessed
by LDH release. sfRNA production alone did not lead to signifi-
cant cell death (Figure 6D), indicating that sfRNA must act in the
context of viral infection to promote virus-induced cytopathicity.
In order to confirm the role of sfRNA in virus-induced cytopa-
thicity, the defect in sfRNA production was complemented by
providing sfRNA1 in trans from transfected pCMVbgal30. The cy-
topathicity of FL-IRADCS3 was, indeed, partially rescued in cells
producing sfRNA from the transfected plasmid as determined by
LDH release (Figure 6E). This was confirmed by the detection of
more clear plaques in cells transfected with pCMVbgal30 and in-
fected with FL-IRADCS3 than in infected cells transfected with
the control pCMVbgal (Figure 6F). In addition, viral titers were
significantly increased in cells transfected with pCMVbgal30
and infected with FL-IRADCS3 compared to those in infected
cells transfected with the control plasmid (Figure 6G). In
these experiments, transfection efficiency was between 50%
and 60%, while 100% of cells were infected as determined by
X-gal staining and immunofluorescence analyses, respectively
(data not shown). Thus, the relatively inefficient but significant
complementation can be explained by the limited transfection
efficiency of the plasmid supplying the complementing sfRNA.
Overall, the results demonstrate that production of abundant
amounts of sfRNA1 during virus infection is a determinant of viral
cytopathicity in cell culture.
sfRNA1 Is Required for Viral Pathogenicity in Mice
To investigate the effect of altered sfRNA production on viral
pathogenicity in vivo, FLSDX, FL-IRA, FLDCS3, and FL-
IRADCS3 were injected in 3-week-old mice, a highly sensitive
animal model for WNVKUN infection. Mice infected with the
wild-type virus FLSDX started to develop severe symptoms as
early as day 6 after injection, and all animals had to be sacrificed
9 days after injection (Figure 7A). Mice injected with FLDCS3,
which produces less sfRNA1, developed symptoms after
7 days, with a mortality rate of 60% throughout the observation
period (Figure 7A). In contrast, mice injected with either FL-IRA
or FL-IRADCS3 showed no signs of WNVKUN-induced encepha-
litis during the observation period (Figure 7A). Kinetic analysis of
virus accumulation in the spleen and brain of infected mice& Microbe 4, 579–591, December 11, 2008 ª2008 Elsevier Inc. 583
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sfRNA mutant viruses being detected in the brain later in infec-
tion at levels similar to corresponding parental viruses (i.e.,
FLSDX for FL-IRA and FLDCS3 for FL-IRADCS3; Figures 7B
and 7C). The results show that the production of sfRNA1 is not
essential for viral replication and spread in vivo, while it has a
crucial role in determining viral pathogenicity.
DISCUSSION
We demonstrated that all representative viruses from the genus
Flaviviruses, but not from other genera of the Flaviviridae family,
produce an abundant, subgenomic, noncoding RNA derived
from the 30UTR of gRNA. We have shown that RNA replication,
viral proteins, or 50UTR are not essential for generation of this
subgenomic flavivirus RNA (sfRNA). We have provided evidence
that sfRNA is a product of incomplete degradation of gRNA,
which is likely to involve cellular 50-30 exoribonuclease XRN1,
one of the key enzymes in the cellular mRNA decay pathway.
In agreement with the high level of conservation between factors
and pathways involved in mRNA decay of mosquito and human
cells (Opyrchal et al., 2005), sfRNA was produced in cells of
different origin, including mosquito cells.
In general, mRNA decay in the cell can follow different path-
ways. It can be regulated by decapping, deadenylation, transla-
tion, cis-acting elements, and ‘‘nonsense’’ sequences and has
been shown to be a critical control point for determination of
transcript abundance (Wilusz et al., 2001). 50-30 mRNA degrada-
tion takes place in PBs, which contain most enzymes and
proteins needed for the basic decay machinery (Newbury
et al., 2006). Our viral RNA and XRN1 colocalization results sug-
gest that XRN1-mediated production of sfRNA in infected cells is
likely to take place in PBs. However, it remains elusive how and
why the viral genomic RNA is targeted to this RNA decay path-
way. It is possible that viral gRNA molecules containing
nonsense mutations and, thus, not being able to participate in
translation, replication, or packaging can be targeted to PBs
for degradation. Once in the PB, gRNA can be decapped and
then degraded by XRN1 until the enzyme is stalled on rigid struc-Cell Hosttures in the beginning of 30UTR, ultimately resulting in production
of sfRNA. The resistance of sfRNA to degradation by XRN1
shown here by in vitro digestion of viral RNA from infected cells
using recombinant XRN1 supports this hypothesis. However the
role of other ribonucleases present in infected cells in the gener-
ation of nuclease-resistant sfRNA cannot be ruled out. A recent
study with a segmented positive-strand RNA virus from plants
described generation of nuclease-resistant small noncoding
RNA derived from the 30UTR of one of the two viral RNAs via in-
complete degradation of gRNAs (Iwakawa et al., 2008). Although
the exclusive role of XRN1 in its generation was not demon-
strated, several lines of evidence implicated the role of a cellular
enzymewith 50-30 exoribonuclease activity in this process. These
results provide additional support for our findings and further
strengthen our hypothesis on the involvement of XRN1 in sfRNA
generation.
The reason why sfRNA production is specific to the flavivirus
genus of the Flaviviridae family and does not occur during infec-
tion with viruses from other genera (i.e., Pesti- and Hepacivi-
ruses) is not entirely clear. The absence of small RNA in cells
containing replicating SFV, HCV, and BVDV RNAs suggests
that these RNAs do not contain structures able to protect against
ribonuclease degradation. In support of the notion that not any
but specifically flavivirus RNA structures are able to inhibit
degradation, the highly structured IRES fromEMCV, inserted up-
stream of the sfRNA 50 end of WNVNY99 replicon, was not able to
do so. Thus, contrary to the current view that the variable 50 part
of the flavivirus 30UTR serves only as a spacer to secure proper
RNA folding of the conserved 30 end of the 30UTR (Proutski et al.,
1999), we now provide compelling experimental evidence that
the 50 part of the 30UTR, in fact, harbors conserved RNA
structures that play an essential role in the formation of sfRNA
required for efficient virus replication and pathogenicity.
The important question is why flaviviruses evolved a strategy
to generate sfRNA and how exactly it contributes to virus replica-
tion, cytopathicity, and pathogenicity. Subgenomic noncoding
RNAs are only produced by a small number of other RNA viruses
(e.g., Soybean dwarf virus [Yamagishi et al., 2003], Barley yellow
dwarf virus [Koev and Miller, 2000], Citrus tristeza virus [AyllonFigure 4. Production of sfRNA Species Is Determined by the Presence of Highly Structured RNA Sequences and Contributes to Virus
Replication
(A) RNA structuremodel ofWNVKUN 3
0UTRgenerated from previously described and newly predicted RNA structures. Positions of nucleotides (nt) from beginning
of the 30UTR and corresponding positions from the end of 30UTR showing sfRNA 50 ends (in brackets) are indicated. IRA, inverted repeat A; IRA0, inverted repeat
A0; (R)CS3/2/1, (repeated) conserved sequence; DB1/2, dumbbell structures; SL, stem-loop structures. Experimentally determined 50 end of sfRNA1 and
predicted 50 ends of sfRNA2 and sfRNA3 are indicated by arrows. Putative pseudoknot interactions are indicated by dashed lines. Colored regions show the
location of introduced deletions.
(B) Secondary RNA structure predictions of SL-II and SL-IV regions (SL-E for YFV) for different flaviviruses generated from sequence alignment. The conserved
RNA structure has the following properties: (1) sfRNA 50 end (determined for WNV and JE) located at base of SL-II, (2) conserved base pairing sequences in
base stem, (3) variable side stem-loop, (4) two conserved unbound C residues at the heart of the structure, (5) conserved base pairing sequences in top
stem, (6) variable top loop with putative pseudoknot interaction (dashed lines with spacer sequence located between SL-II and RCS3 or SL-IV and CS3 or, in
case of YFV, SL-E and SL-D). Nt numbering from the end of 30UTR. sfRNA 50 ends are indicated by arrows. Conserved nt are in red letters with yellow background.
Nt with putative pseudoknot interactions between top loop and spacer between SL-II and RCS3 have gray background. DG values show free minimal energies.
(C) Schematic representation of the WNVKUN genome organization, 3
0UTR, and introduced deletions/mutations. sfRNA 50 end at position 525 is indicated. Nt
positions shown at start and end of deletions correspond to nt in the viral genomic sequence (GenBank accession number AY274504). Nt substitutions in inverted
repeats are indicated with an asterisk.
(D) Northern blot of RNA isolated from BHK-21 cells infected with virus mutants. gRNA, viral genomic RNA; sfRNA, subgenomic flavivirus RNA.
(E) Plaque assays on Vero cells. Cells were fixed and stained with crystal violet 6 d.p.i. sfRNA species (1, 2, or 3) produced by individual virus mutants are
indicated.
(F) Growth kinetics of mutant viruses in mammalian (Vero, upper panel) and mosquito (C6/36, lower panel) cells infected with MOI = 0.1.
Data are represented as average ± SD.& Microbe 4, 579–591, December 11, 2008 ª2008 Elsevier Inc. 585
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Generation and Function of sfRNAFigure 5. sfRNA1 Production Is Required for Efficient Virus Replication in Mammalian and Mosquito Cells
(A) Northern blot of RNA isolated from BHK-21 cells infected with virus mutants. Lane 6 shows a longer exposure of lane 5. gRNA, genomic RNA; sfRNA,
subgenomic flavivirus RNA; rRNA, ribosomal RNA.
(B) Plaque assay on Vero cells. Cells were fixed and stained 6 d.p.i. sfRNA species (1, 2, or 3) produced by individual virus mutants is indicated.
(C) Virus growth kinetics in Vero cells infected with MOI = 1.
(D) Virus growth kinetics in mosquito C6/36 cells infected with MOI = 0.1.
Data are represented as average ± SD.et al., 2004]), but their roles in viral replication or effects on the
infected cell are still largely unexplored. Recent studies with
plant RNA virus, Red clover necrotic mosaic virus, implicated
a role for small noncoding RNA in regulating translation of viral
proteins and negative-strain RNA synthesis but showed little ef-
fect of mutations ablating generation of this noncoding RNA on
virus replication and pathogenicity in plants (Iwakawa et al.,
2008). For flaviviruses, we have shown that the ability to produce
full-length sfRNA is required for efficient virus growth and virus-
induced cytopathicity in cell culture and pathogenicity in mice.
This indicates that sfRNA may play a role in modulating the
host antiviral response via RNA-mediated pathways. Cellular
RNA sensors are responsible for recognition of foreign single-
stranded and double-stranded RNAs and activation of signal
pathways that ultimately lead to activation of the innate immune
response or apoptosis (Yoneyama and Fujita, 2007). By binding
and inactivating one of these sensors, sfRNAmay prevent down-
stream signaling until viral replication is well established. Alterna-
tively, sfRNAmay act as a decoy for cellular miRNAs that may be586 Cell Host & Microbe 4, 579–591, December 11, 2008 ª2008 Elsinduced by the antiviral response and might otherwise target
viral RNA, as recently shown for HCV (Pedersen et al., 2007).
In this scenario, sfRNA would prevent miRNA binding to gRNA
and, thereby, prevent gRNA destruction. The impaired ability of
sfRNA mutants to induce pathological changes in animals
despite their demonstrated ability to reach and replicate in the
brain after peripheral infection indicates that modulation of anti-
viral responses in the brain by sfRNA may be responsible for
virus-induced pathogenicity. In addition, it has been shown
that the cellular mRNA decay machinery can have antiviral func-
tion (Esteban et al., 2008) andmay help to prevent recombination
of viral RNA (Cheng et al., 2006). sfRNA may also function in
inhibiting these activities.
The significantly impaired cytopathicity of viruses failing to
produce sfRNA1 suggests that production of sfRNA1 contrib-
utes to the induction of cell death after infection. To date, cell
death caused by flavivirus infection has been shown to be in-
duced by replication and expression of viral proteins via a variety
of pathways and mechanisms, including apoptosis and necrosisevier Inc.
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Generation and Function of sfRNAFigure 6. sfRNA1 Production Is Essential for Virus-Induced Cytopathicity
(A and B) Vero cells were infected and fixed at indicated time points after infection.
(A) Cells were stained 6 days after infection.
(B) Crystal violet was released from cells by methanol and OD 620 nm measured. Percentage of dead cells was calculated. CPE, cytopathic effect.
(C) LDH release into cell culture fluid of Vero cells infected with mutant viruses was measured 4 d.p.i. by colorimetric assay. Background from negative cells was
subtracted. Percentage of dead cells was calculated.
(D) LDH release from Vero cells transfected with plasmid DNA producing sfRNA (pCMVbgal30).
(E) Partial rescue of virus-induced cytopathicity by complementation with sfRNA. Vero cells were transfected with sfRNA-producing plasmid pCMVbgal30 and
control pCMVbgal. At 24 hr posttransfection, cells were infected with MOI = 1 FLSDX and FL-IRADCS3. LDH release was measured 8 d.p.i.
As a positive control for (C), (D), and (E), mock cells were lysed with 0.1% Triton X-100. Data are represented as average + SD.
(F) Partial rescue of viral plaque formation by sfRNA complementation. Vero cells were transfected with plasmids. At 24 hr later, cells were infected with
corresponding viruses, overlayed with agarose, and stained 6 d.p.i.
(G) Partial rescue of virus production by sfRNA complementation.
Viral titers in culture fluid of DNA-transfected and virus-infected cells (as in [E]) were determined 48 hr after infection by plaque assay on BHK cells. P values were
calculated by unpaired Student’s t test.(Ait-Goughoulte et al., 2007; Medigeshi et al., 2007; Ramanathan
et al., 2006; Su et al., 2002; Yang et al., 2002). Interestingly, pro-
duction of sfRNA1 alone without viral infection did not induce cell
death, while it did complement the cytopathicity of viral mutants
defective in sfRNA production, suggesting that viral factors and/
or cellular factors induced by virus infection may be required forCell HostsfRNA-mediated cell death. Thus, sfRNA production might be
a viral trigger to facilitate cell death; however, identification of
the exact pathway and mechanisms by which sfRNA leads to
cell death requires further experimentation.
In conclusion, we showed that all members of the genus Flavi-
virus encode unique RNA element(s) at the beginning of 30UTR& Microbe 4, 579–591, December 11, 2008 ª2008 Elsevier Inc. 587
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degradation by cellular ribonucleases. The resulting nuclease-
resistant noncoding RNA product plays an important role in the
virus replication cycle and contributes to viral cytopathicity and
pathogenicity. In addition to the high potential of sfRNA mutants
for the development of attenuated flavivirus vaccines, the strong
influence of sfRNA on the viral life cycle can also provide a valu-
able tool to study cellular mechanisms of RNA turnover. Clear
Figure 7. sfRNA1 Production Is a Determinant of Viral Pathogenicity
in Mice
Three-week-old Swiss outbred mice (five per group) were i.p. injected with
10,000 PFU of virus. (A) Mice were monitored daily and sacrificed when
encephalitis symptoms became evident. As a control, five mice were injected
with medium only. These mice remained healthy over the observation period
(data not shown). Relative amounts of sfRNA and sfRNA species produced
by the viruses are indicated. Spleens (B) and brain (C) were recovered from
three infected mice per time point per group, and C6/36 cells were infected
with corresponding homogenates. Presence of infectious virus in infected cells
was determined by ELISA, and OD 405 nm was measured.588 Cell Host & Microbe 4, 579–591, December 11, 2008 ª2008 Elsbiological readout in the form of virus replication, virus-induced
cytopathicity, and viral pathogenicity in laboratory animals may
allow easy and reliable assessment of the effects of various fac-
tors on the biogenesis and functions of the cellular RNA decay
machinery. Our findings offer valuable insight into the fields of
virology and cell biology and provide significant contribution to
the research concerning noncoding RNA-mediated mechanisms
of viral pathogenicity and mechanisms of cellular RNA decay.
EXPERIMENTAL PROCEDURES
Construction of Mutant Viruses and RNA Electroporation
WNVKUN full-length cDNA clone FLSDX (pro)_HDVr (designated FLSDX) was
described previously (Liu et al., 2003). A XmaI-XhoI fragment from FLSDX
(pro)_HDVr was cloned into pBluescript generating pBS-30XX. Mutations and
deletions in the WNVKUN 3
0UTR were engineered into pBS-30XX using
Quickchange PCR site-directed mutagenesis with primers listed (Table S1).
Presence of mutations was confirmed by sequencing, and fragments were
reinserted into FLSDX (pro)_HDVr. Full-length cDNA clones were linearized
and purified. In vitro RNA transcription and electroporation of BHK-21 cells
were performed as described previously (Khromykh and Westaway, 1997).
Recovered viruses were amplified on BHK-21 cells to generate virus stocks.
Virus titers were determined by standard plaque assay on BHK-21 cells. Viral
RNA was isolated from virus stocks, amplified by RT-PCR, and sequenced to
confirm presence of the mutations. Virus stocks were stored in 0.5 ml aliquots
at –80C.
Plasmid Construction and DNA Transfection
pKUNrep2-bgal, pKUNrep2-bgalDGDD, and pKUNrep3-bgal were described
previously (Varnavski et al., 2000). pKUNrep3-bgalDNS1, pKUNrep3-
bgalDNS1/5AB, and pKUNrep3-bgalDNS1/3/5 were created essentially as
described (Khromykh, 2000). pKUNrep2-bgalDBsrGI and pKUNrep2-bgalDX-
baI were created by deleting BsrGI and XbaI fragments from pKUNrep2-bgal,
respectively. Although these replicon constructs are defective in RNA replica-
tion, translation of the encoded polyprotein was efficient (data not shown).
pCMV50bgal30 and pCMVbgal30 were created by PCR-directed deletion
mutagenesis with overlapping primers (Table S1) using pKUN1 (Khromykh
et al., 2001) as a template. The bgal gene from repPAC-bgal (Liu et al., 2002)
was subsequently inserted as an NsiI fragment. DNA transfection was carried
out using Lipofectamine (Invitrogen) following the manufacturer’s protocol.
Virus Infection, Growth Kinetics, and Plaque Assay
Vero and C6/36 cells were infected at a multiplicity of infection (MOI) of 0.1 to
1 for 2 hr at 37C, washed three times with PBS, and overlaid with DMEM con-
taining 2% FBS. For growth curves, cell culture fluid from 6-well plates was
harvested at the indicated times postinfection to determine virus titers by stan-
dard plaque assay onBHK-21 cells. For plaque assays, BHK-21 or Vero cells in
6-well plates were infected with a dilution series of viruses as described above.
Cells were overlaid with 0.75% LMP agarose in DMEM containing 2% FCS,
incubated at 37C for 4 (BHK-21) or 6 (Vero) days, fixed with 10% formalde-
hyde, and stained with 0.2% crystal violet.
RNA Isolation and Northern Hybridization
Mouse brain tissue infected with WNVKUN strain MRM61C (Khromykh and
Westaway, 1994) was used as a source for RNA extraction. WNVKUN virions
(generated from FLSDX) were purified from culture fluid of infected BHK cells
by continuous sucrose gradient (5%–25% w/v) and tested for infectivity by
plaque assay. RNA was isolated with Trizol (Invitrogen) following the manufac-
turer’s recommendations. Total RNA from Huh-7 cells transfected with HCV
replicon C5B was a gift from Dr. Michael Beard.
Total RNA (10 mg) was subjected to denaturing gel electrophoresis in
a 1.5% agarose, 2% formaldehyde gel followed by transfer onto Hybond-N
membranes (Amersham, Buckinghamshire, UK). Membranes were dried,
RNA crosslinked by UV-irradiation for 2 min, and hybridized for 1 hr with
[32P]-labeled (Perkin Elmer, Waltham, USA) 30UTR probes in ExpressHyb
solution (Clontech, Mountain View, USA) following the manufacturer’sevier Inc.
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phorscreen, and signals were quantified using a Typhoon phosphorimager
(Amersham).
Nuclease Assays
RNA isolated from infected BHK cells was digested with the indicated
amount of XRN1 (Epicenter, Madison, USA), RNaseONE (Promega), or
RNaseA (Epicenter) for 30min at 30C and prepared for northern hybridization.
siRNA Knockdown of XRN1 and Western Blotting
A549 or SVGA cells were seeded in 6-well plates and transfected three times
with 24 hr intervals using Lipofectamine 2000 (Invitrogen) and 20 pmol of amix-
ture of three Stealth siRNAs against human XRN1 or Stealth siRNA against
eGFP (Invitrogen) following the manufacturer’s protocol. Proteins were sepa-
rated in 12.5% SDS-PAGE gels and transferred to Hybond ECL membranes
(Amersham). Immunodetection was performedwith a cocktail of mousemono-
clonal antiserum against NS5 (1:200) and a rabbit polyclonal antiserum against
human XRN1 (1:1000; Novus Biologicals, Littleton, USA). Secondary anti-
bodies were IRdye800 anti-rabbit (1:5000; Rockland Immunochemicals, Gil-
bertsville, USA) and AlexaFluor680 anti-mouse (1:5000; Molecular Probes,
Carlsbad, USA). Dried blots were scanned on an Odyssey infrared imager
(LI-COR Biosciences, Lincoln, USA).
Fluorescent In Situ Hybridization and Immunofluorescence
Analyses
The FITC-labeled, 30UTR-specific probe was generated by in vitro transcrip-
tion using T3 RNA polymerase, pBS-30XX plasmid described above, and a
fluorescein RNA labeling mix (Roche, Australia). After transcription, alkali
hydrolysis was performed. To generate SFV 30UTR probe, RNA isolated
from SFV-infected cells was subjected to RT-PCR specific for the 30UTR
with a Sp6 promoter-containing primer. This PCR product was used for
in vitro transcription with Sp6 polymerase as above.
A549 cells were seeded on coverslips and infectedwith FLSDX atMOI = 2 as
described above. At 24 or 30 hr after infection, cells were fixed with 4%
paraformaldehyde and permeabilized with 0.2% Triton X-100. FISH probe
was diluted 1:100 in hybridization buffer, and coverslips were incubated with
the probe overnight at 45C. Coverslips were washed with 0.1 3 SSC and
PBS and incubated with rabbit anti-XRN1 antibody (1:500), which was
detected with an AlexaFluor549 anti-rabbit antibody (Molecular Probes).
Nuclei were counterstained with DAPI. Pictures were acquired using a Zeiss
Axiophot 2 microscope equipped with an AxioCam MRm camera and AxioVi-
sion AC software. The percentage of colocalization at 30 hr postinfection
(h.p.i.) was calculated as the average percentage ratio of dually labeled
(yellow) spots to FISH-labeled (green) spots in five different areas on two
different coverslips. For SFV-FISH, A549 cells were infected at MOI = 1 and
stained 24 h.p.i as described above.
RNA Structure Prediction and Modeling
A secondary structure model of the entire WNVKUN 3
0UTR was generated
based on a previously generated cotranscriptional model of the 30UTR (Prout-
ski et al., 1999) from RCS3 onward using the STAR program (Gultyaev et al.,
1995; van Batenburg et al., 1995). Similar folds of the dumbbell structures con-
taining RCS2/CS2 with putative pseudoknots pk2 and pk1 (Olsthoorn and Bol,
2001) and the 30SL (Hahn et al., 1987; Shi et al., 1996; Wengler and Castle,
1986) were published previously. The SL-I structure at the 50 end of the
30UTR was generated using Mfold (this study). A common structure prediction
for aligned SL-II and SL-IV sequences was generated by Pfold (Knudsen and
Hein, 2003). Free energy values of individual SL-II and SL-IV structures were
calculated by Mfold using forced base pairing. Putative pseudoknot interac-
tions were located manually.
Cytopathicity and Complementation Assays
Vero cells were seeded into 24-well plates and infected with MOI = 0.1 as
described above. At 3 to 8 days after infection, CPE was assessed as
described previously (Liu et al., 2006). LDH release from cells was measured
with Cytotoxicity Detection Kit (Roche, Mannheim, Germany) according to
the manufacturer’s instructions.Cell HostTo assess cytotoxicity of sfRNA expressed from plasmid DNA, Vero cells
were transfected with 500 ng pCMVbgal30, and control pCMVbgal plasmid
and cell culture supernatant was harvested for LDH assay 48 hr after transfec-
tion. Transfection efficiency determined by X-gal staining was between 50%
and 60%. To complement sfRNA, Vero cells plated at a density of about
50% were transfected with 500 ng pCMVbgal30 and control pCMVbgal. At
24 hr after transfection, cells were infected with FLSDX and FL-IRADCS3 at
MOI = 1. At 8 days after infection, cell culture supernatant was harvested
and LDH release measured. In parallel, supernatant from transfected and
infected cultures was harvested 48 hr after infection and viral titers determined
by plaque assay. To assess plaque formation after transfection, cells in 6-well
plates were transfected with 1.5 mg DNA/well and infected 24 hr later for
plaque assay as described above.
Mouse Virulence Study and Determination of Viral Burden
Groups of fivemice were injected intraperitoneally with 10,000 plaque-forming
units (PFU) of the different viruses in DMEM. As control, fivemice were injected
with DMEM. Mice were monitored for 14 days three times per day for clinical
symptoms of WNV infection (ruffled fur, antisocial behavior, paralysis,
hunched posture). Mice that showed clear symptoms of encephalitis were
euthanized. For the analysis of viral burden in brain and spleen of infected
mice, organs from three mice each were recovered at days 2, 3, and 5 after in-
fection, weighed, and homogenized inmedium using beads. Homogenate was
centrifuged, and supernatant was used to infect duplicate wells of C6/36 cells.
The presence of virus was determined by ELISA 7 days after infection using
monoclonal anti-E antibodies as described previously (Hall et al., 2003). The
experiments were conducted with approval from the University of Queensland
Animal Experimentation Ethics Committee in accordance with the guidelines
for animal experimentation as set out by the National Health and Medical
Research Council, Australia.
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Text, Experimental Procedures,
one table, and five figures and can be found with this article online at http://
www.cellhostandmicrobe.com/supplemental/S1931-3128(08)00334-X.
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